InvestorsHub Logo
Followers 19
Posts 1331
Boards Moderated 0
Alias Born 10/30/2012

Re: BluSkies post# 6

Thursday, 11/21/2013 9:08:33 AM

Thursday, November 21, 2013 9:08:33 AM

Post# of 1739
Both.. Plus filling the gap from the Monday open.

As soon as they release a PR now that their IPO quiet period is over, we should see some interest return this over IPO pricing.

The Aegis Capital Corp. analyst, Raghuram Selvaraju, Ph.D, who offered an 18 month price target of $60 which caused the spike into the low $12s, is HIGHLY regarded in the bio-tech sector.

http://www.thelifesciencesreport.com/pub/htdocs/expert.html?id=7096

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News